Larimar Therapeutics Inc (LRMR): December discounts. With 85 million in...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	502
Posts	18338
Boards Moderated	0
Alias Born	08/17/2012

Fat Thor

Re: casenumber post# 309

Wednesday, 12/18/2019 3:36:10 PM

Wednesday, December 18, 2019 3:36:10 PM

December discounts. With 85 million in cash, a merger, and priced at 67 cents there's no way this doesn't run soon. 35 million O/S.

Keep Last Read

Replies (2) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent LRMR News

Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 08:09:50 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:06:02 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/15/2024 01:57:52 AM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/14/2024 10:08:46 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 01:55:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 11:06:09 AM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/13/2024 09:46:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 12:03:55 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 09:33:33 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 09:32:58 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 09:31:40 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 09:31:11 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 09:08:38 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 06:51:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 08:31:01 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 12:00:23 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:05:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 11:03:03 AM
Larimar Therapeutics Shares Rise 10% After FDA Clears CTI-1601 Trial • Dow Jones News • 07/25/2023 05:06:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2023 11:02:05 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/18/2023 08:15:06 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/18/2023 08:13:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2023 08:08:34 PM

More LRMR News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover